What is the recommended oral dose of Terbinafine (Lamisil) for fungal infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Oral Terbinafine Dosing for Fungal Infections

The standard recommended dose of oral terbinafine for fungal infections is 250 mg daily for adults, with treatment duration of 6 weeks for fingernail infections and 12 weeks for toenail infections. 1, 2

Adult Dosing

  • Terbinafine 250 mg daily is the standard adult dose for dermatophyte infections 1, 2
  • Treatment duration varies by infection site:
    • Fingernail infections: 6 weeks 1, 2
    • Toenail infections: 12 weeks 1, 2
  • Patients should be re-evaluated 3-6 months after treatment initiation to assess response 2

Pediatric Dosing

Terbinafine dosing for children is weight-based 1:

  • < 20 kg: 62.5 mg daily 1
  • 20-40 kg: 125 mg daily 1
  • 40 kg: 250 mg (adult dose) daily 1

  • Duration: 6 weeks for fingernail infections and 12 weeks for toenail infections 1

Special Populations

Diabetic Patients

  • Terbinafine is the oral antifungal of choice for diabetic patients with onychomycosis 1
  • Standard adult dosing applies (250 mg daily) 1
  • Preferred over itraconazole due to lower risk of drug interactions and no contraindication in cardiac disease 1

Immunosuppressed Patients

  • Terbinafine is preferred over itraconazole and ketoconazole in immunosuppressed patients (including HIV) due to lower risk of interactions with antiretrovirals 1
  • Standard adult dosing applies (250 mg daily) 1

Monitoring and Safety Considerations

  • Baseline liver function tests are recommended before starting treatment 2, 3
  • More vigilant monitoring is advised in patients with 2:
    • Pre-existing liver disease
    • Concomitant hepatotoxic medications
    • Continuous therapy for more than one month
    • History of heavy alcohol consumption

Contraindications

  • Active or chronic liver disease 1, 2
  • History of allergic reaction to oral terbinafine 3
  • Lupus erythematosus 2, 3

Clinical Efficacy

  • Terbinafine has demonstrated superior efficacy compared to other antifungals for dermatophyte infections 4
  • Mycological cure rates of >80% have been reported in clinical trials 5
  • A randomized study showed that 12 weeks of treatment was optimal for toenail onychomycosis, with 71% cure rate at 48 weeks follow-up 6

Common Side Effects

  • Gastrointestinal symptoms (most common): nausea, diarrhea, dyspepsia 3, 7
  • Taste disturbance (usually improves after stopping treatment) 3
  • Rash and pruritus 3, 7
  • Headache 3

Drug Interactions

  • Terbinafine has minimal drug interactions compared to azole antifungals 1, 2
  • Main interaction concern is with drugs metabolized by cytochrome P450 2D6 isoenzyme 1, 2

Important Clinical Pearls

  • Terbinafine is fungicidal against dermatophytes with very low minimum inhibitory concentrations (approximately 0.004 μg/mL) 2
  • It can be taken with or without food 3
  • Nail terbinafine concentrations are detected within 1 week after starting therapy and persist for at least 30 weeks after completing treatment 4
  • For Candida infections, itraconazole is generally preferred over terbinafine due to better efficacy 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.